Skip to main content
TipRanks
Go Ultimate75% OFF

John Kenneth Amory Insider Profile

4 Followers

John Kenneth Amory, former Director at Clarus Therapeutics Holdings, holds 5.77K shares in Clarus Therapeutics Holdings (Ticker: CRXTQ).

John Kenneth Amory's Trading History

CRXTQ
Clarus Therapeutics Holdings
Jun 09, 2022―Uninformative Buy―$57.66
CRXTQ

John Kenneth Amory has not reported any informative transactions for CRXTQ, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 09, 2022Uninformative Buy$0.001,922$0.00―
Dec 14, 2021Uninformative Buy$0.003,844$0.00―

You May Also Like

John Kenneth Amory insider profile FAQ

What stocks does John Kenneth Amory hold?
John Kenneth Amory holds: CRXTQ stocks.
What is John Kenneth Amory's role in Clarus Therapeutics Holdings?
John Kenneth Amory's role in Clarus Therapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.